4.93 USD
-0.12 (-2.38%)
4.87 USD
-0.06 (-1.22%)
ChartMill assigns a Buy % Consensus number of 80% to RADX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 5.39. This target is 9.42% above the current price.
- RADX was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RADX.
- In the previous month the buy percentage consensus was at a similar level.
- RADX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-16 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-11-26 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-07-21 | Brookline Capital | Initiate | Buy |
| 2025-05-01 | Maxim Group | Initiate | Buy |
| 2025-03-12 | B. Riley Securities | Initiate | Buy |
RADIOPHARM THERANOSTICS LTD / RADX FAQ
What do analysts expect the price target to be for RADIOPHARM THERANOSTICS LTD (RADX)?
6 analysts have analysed RADX and the average price target is 5.39 USD. This implies a price increase of 9.42% is expected in the next year compared to the current price of 4.93.
What is the consensus rating for RADX stock?
The consensus rating for RADIOPHARM THERANOSTICS LTD (RADX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for RADIOPHARM THERANOSTICS LTD stock?
The number of analysts covering RADIOPHARM THERANOSTICS LTD (RADX) is 6.